Kentucky AG Settles OxyContin, Risperdal Suits For $39.5M
Purdue Pharma LP and Johnson & Johnson will pay a combined $39.5 million to settle respective lawsuits over the narcotic OxyContin and antipsychotic Risperdal brought by the state of Kentucky, its...To view the full article, register now.
Already a subscriber? Click here to view full article